Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

EMA committee hands down negative opinion for enclomiphene MAA

Jan. 29, 2018

Boehringer Ingelheim identifies novel cytochrome P450 11B2 inhibtors

Jan. 26, 2018

EMA committee gives positive opinion on orphan drug status for OMS-721

Jan. 23, 2018

FDA accepts two IND applications for OP-687

Jan. 18, 2018

FDA advisory committee votes against testosterone replacement therapy Tlando

Jan. 12, 2018

Novel TrpC5 ion channel inhibitor shows promise in models of progressive kidney disease

Jan. 9, 2018

EMA accepts CMA application for avacopan for ANCA-associated vasculitis

Jan. 4, 2018

FDA approves expanded indication for Procysbito to include children 1 year of age and older

Dec. 29, 2017

Bayer initiates phase III studies in Japan of molidustat in nondialysis patients with renal anemia

Dec. 28, 2017

Achillion Pharmaceuticals' ACH-4471 receives U.S. orphan drug designation

Dec. 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...